Pharmaron Beijing (03759): The group collaborates with multiple companies in different fields to advance its own business development goals.
Kanglong Chemicals (03759) has issued an announcement regarding recent news reports about the Group's production cooperation with a Chinese subsidiary of an international leading pharmaceutical company. After conducting a reasonable inquiry into the matter, the company has confirmed that the aforementioned production cooperation was entered into as part of the Group's routine and normal business processes. In the course of its daily operations, the Group collaborates with multiple companies in different fields to advance its business development goals. Additionally, the company is not aware of any material that needs to be disclosed to avoid false market representation of the company's securities, nor is it aware of any insider information that must be disclosed in accordance with Listing Rule 13.09(2) and the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) Part XIVA.
Pharmaron Beijing (03759) announces that, regarding recent news reports about the Group's production cooperation with a Chinese subsidiary of a leading international pharmaceutical company, the company has conducted a reasonable inquiry and confirmed that the aforementioned production cooperation was established as part of the Group's daily and general business activities. The Group collaborates with multiple companies in various fields in its daily operations to promote its business development goals. Furthermore, the company is not aware of any material that needs to be disclosed to prevent the occurrence of false market for the company's securities, nor does it have any insider information that needs to be disclosed in accordance with Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).
Related Articles

US Stock Market Move | Revenue reached a record high for fiscal year 2025. EHang Holdings Ltd. Sponsored ADR Class A (EH.US) opened with nearly an 8% increase.

OOIL (00316) will distribute a final dividend of $0.42 per share on June 30th.

CICC (03908): In 2026, publicly issued perpetual subordinated bonds (third tranche) with a face interest rate of 2.24% targeting professional investors.
US Stock Market Move | Revenue reached a record high for fiscal year 2025. EHang Holdings Ltd. Sponsored ADR Class A (EH.US) opened with nearly an 8% increase.

OOIL (00316) will distribute a final dividend of $0.42 per share on June 30th.

CICC (03908): In 2026, publicly issued perpetual subordinated bonds (third tranche) with a face interest rate of 2.24% targeting professional investors.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


